BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND PDGFRB, JTK12, 5159, P09619, ENSG00000113721, PDGF-R-beta, PDGFR1, CD140B, PDGFR, CD140b
425 results:

  • 1. World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.
    Shomali W; Gotlib J
    Am J Hematol; 2024 May; 99(5):946-968. PubMed ID: 38551368
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. B-cell ALL with SOX11 gene amplification associates with a worse outcome.
    Angelakakis G; Varkhedi M; Dabkowski TR; Diaz MJ; Yeagley M; Blanck G
    Cell Cycle; 2024 Jan; 23(1):36-42. PubMed ID: 38350028
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The novel TERF2::pdgfrb fusion gene enhances tumorigenesis via pdgfrb/STAT5 signalling pathways and sensitivity to TKI in ph-like ALL.
    Xu GF; Zeng Z; Zhang ZB; Zhang XM; Wang M; Xiao Q; Li J; Xie XQ; He S; Fu HH; Liu Y; Yang ZL; Chen Y; Shi J; Wang B; Qiu HY; Zhou Q; Liu Y; Chen SN
    J Cell Mol Med; 2024 Feb; 28(3):e18114. PubMed ID: 38323741
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Myeloid and lymphoid neoplasm with novel complex translocation: unusual case report with T-lymphoblastic lymphoma, myeloid hyperplasia, eosinophilia, basophilia, and t(1;8;10)( (p31;q24;q11.2).
    Aljabry MS
    J Hematop; 2023 Mar; 16(1):27-31. PubMed ID: 38175368
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Resistance to apoptosis in complicated Crohn's disease: Relevance in ileal fibrosis.
    Seco-Cervera M; Ortiz-Masiá D; Macias-Ceja DC; Coll S; Gisbert-Ferrándiz L; Cosín-Roger J; Bauset C; Ortega M; Heras-Morán B; Navarro-Vicente F; Millán M; Esplugues JV; Calatayud S; Barrachina MD
    Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166966. PubMed ID: 37995775
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Identification of a Selective FLT3 Inhibitor with Low Activity against VEGFR, FGFR, pdgfr, c-KIT, and RET Anti-Targets.
    Akwata D; Kempen AL; Dayal N; Brauer NR; Sintim HO
    ChemMedChem; 2024 Jan; 19(1):e202300442. PubMed ID: 37971283
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Analysis of CD74 Occurrence in Oncogenic Fusion Proteins.
    Vargas J; Pantouris G
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958963
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Targeting hyperactive platelet-derived growth factor receptor-β signaling in T-cell acute lymphoblastic leukemia and lymphoma.
    De Coninck S; De Smedt R; Lintermans B; Reunes L; Kosasih HJ; Reekmans A; Brown LM; Van Roy N; Palhais B; Roels J; Van der Linden M; Van Dorpe J; Ntziachristos P; Van Delft FW; Mansour MR; Pieters T; Lammens T; De Moerloose B; De Bock CE; Goossens S; Van Vlierberghe P
    Haematologica; 2024 May; 109(5):1373-1384. PubMed ID: 37941480
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Design, synthesis, and evaluation of new benzimidazole‏ ‏‎thiourea ‎derivatives as antitumor agents.
    Aboutaleb MH; El-Gohary NS; Ghabbour HA; El-Kerdawy MM
    Arch Pharm (Weinheim); 2023 Nov; 356(11):e2300269. PubMed ID: 37602810
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Acute myeloid leukemia with LRRFIP1::FGFR1 rearrangement and a complex karyotype.
    Qian YW; Wang ES; Sait SJ; Glenn ST
    Cancer Genet; 2023 Nov; 278-279():50-54. PubMed ID: 37597337
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A novel subclonal rearrangement of the STRN3::pdgfrb gene in de novo acute myeloid leukemia with NPM1 mutation and its leukemogenic effects.
    Wang Z; Liu T; Liu W; Gao X; Wan L; Qiu S; Song Y; Gu R; Tian Z; Wang M; Wang J; Mi Y; Wei S
    Cancer Gene Ther; 2023 Nov; 30(11):1471-1484. PubMed ID: 37550570
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Causes of death and treatment-related mortality in newly diagnosed childhood acute lymphoblastic leukemia treatment with Chinese Children's Cancer Group study ALL-2015.
    Liu K; Shao J; Cai J; Tang J; Shen S; Xu F; Ren Y; Zhang A; Tian X; Lu X; Hu S; Hu Q; Jiang H; Zhou F; Liang C; Leung AWK; Zhai X; Li C; Fang Y; Wang Z; Wen L; Yang H; Wang N; Jiang H
    Ann Hematol; 2023 Dec; 102(12):3431-3444. PubMed ID: 37550503
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort.
    Metzgeroth G; Steiner L; Naumann N; Lübke J; Kreil S; Fabarius A; Haferlach C; Haferlach T; Hofmann WK; Cross NCP; Schwaab J; Reiter A
    Leukemia; 2023 Sep; 37(9):1860-1867. PubMed ID: 37454239
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. SHIP1 Is Present but Strongly Downregulated in T-ALL, and after Restoration Suppresses leukemia Growth in a T-ALL Xenotransplantation Mouse Model.
    Ehm P; Rietow R; Wegner W; Bußmann L; Kriegs M; Dierck K; Horn S; Streichert T; Horstmann M; Jücker M
    Cells; 2023 Jul; 12(13):. PubMed ID: 37443832
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Research Progress of m6A Demethylase FTO and Its Inhibitors in Acute Myeloid leukemia --Review].
    Fang ZH; Zheng SY; Feng WY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):902-906. PubMed ID: 37356958
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Combined treatment with crizotinib and temsirolimus is an effective strategy in mantle cell lymphoma and can overcome acquired resistance to temsirolimus.
    Moosburner M; Alibegovic L; Hasselmann K; Gaiderov A; Hildebrand J; Philippou-Massier J; Blum H; Fischer L; Dreyling M; Silkenstedt E
    Hematol Oncol; 2023 Dec; 41(5):858-868. PubMed ID: 37300279
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Rapid molecular response to dasatinib in Ph-like acute lymphoblastic leukemia patients with ABL1 rearrangements: case series and literature review.
    Tan KW; Zhu YY; Qiu QC; Wang M; Shen HJ; Huang SM; Cao HY; Wan CL; Li YY; Dai HP; Xue SL
    Ann Hematol; 2023 Sep; 102(9):2397-2402. PubMed ID: 37103615
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Prognostic analysis of children with Philadelphia chromosome-like acute lymphoblastic leukemia common genes].
    Hu WD; Li B; Su SF; Liu YF; Liu W; Zhang WL; Zuo WL; Yu RH
    Zhonghua Er Ke Za Zhi; 2023 May; 61(5):446-452. PubMed ID: 37096265
    [No Abstract]    [Full Text] [Related]  

  • 19. Improved survival of patients with primary plasma cell leukemia with VRd or daratumumab-based quadruplets: A multicenter study by the Greek myeloma study group.
    Katodritou E; Kastritis E; Dalampira D; Delimpasi S; Spanoudakis E; Labropoulou V; Ntanasis-Stathopoulos I; Gkioka AI; Giannakoulas N; Kanellias N; Papadopoulou T; Sevastoudi A; Michalis E; Papathanasiou M; Kotsopoulou M; Sioni A; Triantafyllou T; Daiou A; Papadatou M; Kyrtsonis MC; Pouli A; Kostopoulos I; Verrou E; Dimopoulos MA; Terpos E
    Am J Hematol; 2023 May; 98(5):730-738. PubMed ID: 36869876
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Cardiovascular morbidity following conventional therapy versus allogeneic hematopoietic stem cell transplantation after childhood, adolescent, and young adult leukemia in Finland.
    Kero AE; Taskinen M; Volin L; Löyttyniemi E; Itälä-Remes M; Lähteenmäki PM
    Int J Cancer; 2023 Jun; 152(11):2292-2302. PubMed ID: 36760204
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 22.